The MarginProbe™, currently in clinical trials, is designed for use as an intraoperative probe in breast lumpectomy procedures to aid in the selection of tissue abnormalities for excision and for intraoperative margin assessment. The clinical benefit of MarginProbe™ will be the ability to provide the surgeon with an indication of the malignancy status of the margin of the excised tissue, in real time. Thus, surgeons will be able to react to this information before the procedure is over and, where appropriate, remove the suspected residuals.
|
 |
|
